NHI (National Health Investors)
Insider Trading Activity
Every open-market purchase and sale reported by NHI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-30 | Christian Ken Maingot | Chief Operating Officer | A | — | — |
| 2026-06-15 | ROBERT A MCCABE JR | Director | Buy | — | — |
| 2026-06-09 | James R Jobe | Director | G | — | — |
| 2026-06-05 | D. Eric Mendelsohn | CEO and President | Buy | — | — |
| 2026-05-07 | John L Spaid | CFO/EVP Finance | F | — | — |
| 2026-05-07 | David L Travis | SVP/Chief Accounting Officer | F | — | — |
| 2026-05-07 | D. Eric Mendelsohn | CEO and President | F | — | — |
| 2026-03-30 | John L Spaid | CFO/EVP Finance | A | — | — |
| 2026-03-30 | KEVIN CARLTON PASCOE | Chief Investment Officer | A | — | — |
| 2026-03-05 | TRACY M J COLDEN | Director | A | — | — |
| 2026-03-05 | Elizabeth Jackson Blankenship | SVP, Legal Affairs | A | — | — |
| 2026-03-05 | James R Jobe | Director | A | — | — |
| 2026-03-05 | ROBERT A MCCABE JR | Director | A | — | — |
| 2026-03-05 | KEVIN CARLTON PASCOE | Chief Investment Officer | A | — | — |
| 2026-03-05 | Robert Chapin | Director | A | — | — |
| 2026-03-05 | Lilly Donohue | Director | A | — | — |
| 2026-03-05 | Candice W Todd | Director | A | — | — |
| 2026-03-05 | D. Eric Mendelsohn | CEO and President | MIXED | — | — |
| 2026-03-05 | John L Spaid | CFO/EVP Finance | MIXED | — | — |
| 2026-03-05 | David L Travis | SVP/Chief Accounting Officer | MIXED | — | — |
| 2026-02-25 | David L Travis | SVP/Chief Accounting Officer | MIXED | — | — |
| 2026-02-25 | John L Spaid | CFO/EVP Finance | MIXED | — | — |
| 2026-02-25 | D. Eric Mendelsohn | CEO and President | MIXED | — | — |
| 2026-02-25 | KEVIN CARLTON PASCOE | Chief Investment Officer | MIXED | — | — |
| 2026-02-23 | TRACY M J COLDEN | Director | MIXED | — | — |
| 2026-02-19 | D. Eric Mendelsohn | CEO and President | MIXED | — | — |
| 2026-02-19 | James R Jobe | Director | MIXED | — | — |
| 2026-02-17 | ROBERT A MCCABE JR | Director | MIXED | — | — |
| 2026-02-13 | KEVIN CARLTON PASCOE | Chief Investment Officer | MIXED | — | — |
| 2026-02-11 | David L Travis | SVP/Chief Accounting Officer | MIXED | — | — |
| 2026-02-09 | Candice W Todd | Director | MIXED | — | — |
| 2026-02-03 | Kristin Sallee Gaines | SVP/Chief Transaction Officer | M | — | — |
| 2026-02-03 | KEVIN CARLTON PASCOE | Chief Investment Officer | MIXED | — | — |
| 2026-01-29 | ROBERT G ADAMS | Director | MIXED | — | — |
| 2026-01-20 | John L Spaid | CFO/EVP Finance | MIXED | — | — |
| 2026-01-16 | ROBERT A MCCABE JR | Director | MIXED | — | — |
| 2026-01-16 | D. Eric Mendelsohn | CEO and President | MIXED | — | — |
| 2025-12-11 | CHARLOTTE A SWAFFORD | Director | MIXED | — | — |
| 2025-11-24 | James R Jobe | Director | MIXED | — | — |
| 2025-09-25 | David L Travis | SVP/Chief Accounting Officer | MIXED | — | — |
| 2025-05-12 | Robert Chapin | Director | A | — | — |
| 2025-05-07 | John L Spaid | CFO/EVP Finance | F | — | — |
| 2025-05-07 | D. Eric Mendelsohn | CEO and President | F | — | — |
| 2025-04-01 | ROBERT G ADAMS | Director | MIXED | — | — |
| 2025-03-05 | Candice W Todd | Director | A | — | — |
| 2025-03-05 | Kristin Sallee Gaines | SVP/Chief Transaction Officer | A | — | — |
| 2025-03-05 | David L Travis | SVP/Chief Accounting Officer | A | — | — |
| 2025-03-05 | John L Spaid | CFO/EVP Finance | A | — | — |
| 2025-03-05 | TRACY M J COLDEN | Director | A | — | — |
| 2025-03-05 | ROBERT A MCCABE JR | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 342,096 | — |
| — | Director | 170,185 | — |
| — | Senior VP, Finance/Secretary | 135,274 | — |
| — | CEO and President | 133,316 | — |
| — | Director | 132,742 | — |
| — | Director | 122,986 | — |
| — | Director | 90,310 | — |
| — | SVP/Chief Transaction Officer | 80,277 | — |
| — | Chief Investment Officer | 73,082 | — |
| — | CEO and President | 67,419 | — |
| — | CFO/EVP Finance | 56,286 | — |
| — | Chief Accounting Officer | 50,167 | — |
| — | Director | 47,898 | — |
| — | Director | 44,158 | — |
| — | SVP/Chief Accounting Officer | 40,565 | — |
| — | Director | 33,272 | — |
| — | Chief Accounting Officer | 27,129 | — |
| — | Director | 12,858 | — |
| — | Director | 2,563 | — |
| — | SVP, Legal Affairs | 2,420 | — |
| — | Chief Operating Officer | 2,370 | — |
| — | Director | 1,268 | — |
| — | Director | 1,268 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NHI quote page; the site-wide leaderboard is on the insider transactions hub.